readthroughSign in
CompanyOCGNNasdaqMalvern, PA

Ocugen

Ocugen develops modifier gene therapies for blindness diseases including inherited retinal diseases, retinitis pigmentosa, Stargardt disease, and geographic atrophy.

8-KNov 10Latest SEC filing
Nov 10Latest story